Proton therapy combo aims to shrink pancreatic tumors before surgery

NCT ID NCT04894643

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new approach for people with borderline resectable pancreatic cancer, where the tumor is close to important blood vessels but may still be removable. Participants first receive chemotherapy, then proton beam radiation combined with more chemo, followed by surgery if possible. The goal is to see if this treatment is safe and helps control the disease before and after surgery.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

malignant pancreatic neoplasm pancreatic neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Department of Surgery, LK Wiener Neustadt

    RECRUITING

    Wiener Neustadt, 2700, Austria

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • EBG MedAustron GmbH

    RECRUITING

    Wiener Neustadt, Lower Austria, 2700, Austria

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact